Arteris (NASDAQ:AIP) Major Shareholder Sells $718,581.24 in Stock

Arteris, Inc. (NASDAQ:AIP) major shareholder Bayview Legacy, Llc sold 47,244 shares of Arteris stock in a transaction dated Monday, February 9th. The stock was sold at an average price of $15.21, for a total value of $718,581.24. Following the completion of the sale, the insider owned 9,351,827 shares of the company’s stock, valued at approximately $142,241,288.67. The trade was a 0.50% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Bayview Legacy, Llc also recently made the following trade(s):

• On Tuesday, February 10th, Bayview Legacy, Llc sold 2,756 shares of Arteris stock. The stock was sold at an average price of $15.03, for a total value of $41,422.68.
• On Thursday, January 15th, Bayview Legacy, Llc sold 17,884 shares of Arteris stock. The stock was sold at an average price of $17.84, for a total value of $319,050.56.
• On Tuesday, January 13th, Bayview Legacy, Llc sold 2,116 shares of Arteris stock. The stock was sold at an average price of $17.79, for a total value of $37,643.64.
• On Thursday, January 8th, Bayview Legacy, Llc sold 50,000 shares of Arteris stock. The shares were sold at an average price of $16.58, for a total value of $829,000.00.
• On Monday, December 8th, Bayview Legacy, Llc sold 70,000 shares of Arteris stock. The shares were sold at an average price of $17.71, for a total value of $1,239,700.00.
• On Friday, December 5th, Bayview Legacy, Llc sold 60,000 shares of Arteris stock. The stock was sold at an average price of $17.08, for a total transaction of $1,024,800.00.
• On Thursday, December 4th, Bayview Legacy, Llc sold 40,000 shares of Arteris stock. The stock was sold at an average price of $16.46, for a total value of $658,400.00.

Arteris Stock Up 0.1%

Shares of Arteris stock traded up $0.01 during trading on Wednesday, reaching $15.10. The company’s stock had a trading volume of 411,831 shares, compared to its average volume of 427,672. Arteris, Inc. has a 52 week low of $5.46 and a 52 week high of $19.85. The business’s 50-day moving average price is $16.32 and its 200-day moving average price is $13.22. The firm has a market cap of $659.57 million, a PE ratio of -18.19 and a beta of 1.47.

Institutional Investors Weigh In On Arteris

Institutional investors and hedge funds have recently modified their holdings of the company. Intech Investment Management LLC boosted its stake in Arteris by 9.3% during the fourth quarter. Intech Investment Management LLC now owns 13,540 shares of the company’s stock valued at $210,000 after buying an additional 1,148 shares during the period. Deutsche Bank AG increased its stake in shares of Arteris by 7.7% in the fourth quarter. Deutsche Bank AG now owns 21,159 shares of the company’s stock worth $328,000 after buying an additional 1,504 shares during the period. BNP Paribas Financial Markets boosted its holdings in shares of Arteris by 75.0% during the third quarter. BNP Paribas Financial Markets now owns 6,053 shares of the company’s stock worth $61,000 after purchasing an additional 2,595 shares during the period. Public Employees Retirement System of Ohio increased its stake in shares of Arteris by 12.3% during the third quarter. Public Employees Retirement System of Ohio now owns 23,913 shares of the company’s stock valued at $242,000 after buying an additional 2,613 shares during the period. Finally, Strs Ohio boosted its position in Arteris by 16.5% during the 3rd quarter. Strs Ohio now owns 20,500 shares of the company’s stock valued at $207,000 after acquiring an additional 2,900 shares in the last quarter. 64.36% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently commented on AIP shares. TD Cowen restated a “buy” rating on shares of Arteris in a report on Wednesday, November 5th. Rosenblatt Securities reissued a “buy” rating and issued a $20.00 price objective on shares of Arteris in a research note on Monday, December 15th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Arteris in a research report on Wednesday, January 21st. Finally, Jefferies Financial Group raised Arteris to a “hold” rating in a research note on Tuesday, October 28th. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $17.50.

Key Stories Impacting Arteris

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: NXP Semiconductors expanded its deployment of Arteris system IP (FlexNoC, Ncore, CodaCache) and integration tools across AI-enabled SoC, NPU and MCU designs — a clear commercial validation that can drive revenue growth and visibility in edge AI markets. Arteris Technology Deployed More Broadly by NXP
• Positive Sentiment: Institutional buying and analyst coverage remain constructive: multiple funds added AIP in recent quarters and Rosenblatt has a Buy rating (recent median price target ~$18.25), supporting upside vs. current levels.
• Neutral Sentiment: Q4 2025 earnings preview published — upcoming results could move the stock, but the preview itself contains no surprise guidance. Monitor the actual earnings release for revenue/visibility vs. AI-related design wins. What to Expect from Arteris Inc (AIP) Q4 2025 Earnings
• Neutral Sentiment: Short-interest reporting in the recent feeds is inconsistent (entries showing 0 shares or NaN alongside earlier data showing ~1.13M shares shorted as of Jan 30). Data appears noisy — treat short‑interest signals cautiously until exchanges/registrars reconcile the figures.
• Negative Sentiment: Insiders sold stock this week: CEO K. Charles Janac sold 47,244 shares on Feb 9 (~$15.21 avg) and 2,756 shares on Feb 10 (~$15.03 avg); major shareholder Bayview Legacy, LLC reported the same sales. The activity adds to a pattern of frequent insider sales reported over recent months and could weigh on sentiment. SEC filing: Janac insider sales

About Arteris

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.